How can 1 + 1 = 3? β 2-adrenergic and glucocorticoid receptor agonist synergism in obstructive airway diseases

Molecular Pharmacology

Volumn 80, Issue 6, 2011, Pages 955-958

  Martina, Schmidt ^a   Michel, Martin C ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR AGONIST; UNCLASSIFIED DRUG;

DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; HUMAN; MEDICAL LITERATURE; MOLECULAR INTERACTION; NONHUMAN; OBSTRUCTIVE AIRWAY DISEASE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVIEW;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ASTHMA; FEMALE; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 12; SEVERITY OF ILLNESS INDEX;

EID: 81555195477     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.075481     Document Type: Review

References (40)

1. Adcock IM and Barnes PJ (2008) Molecular mechanisms of corticosteroid resistance. Chest 134:394-401.
2. 2-agonists. J Allergy Clin Immunol 110:S261-S268.
3. Barnes PJ (2006a) Corticosteroids: the drugs to beat. Eur J Pharmacol 533:2-14.
4. Barnes PJ (2006b) How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol 148:245-254.
5. Bhavsar P, Hew M, Khorasani N, Torrego A, Barnes PJ, Adcock I, and Chung KF (2008) Relative corticoid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax 63:784-790.
6. Black JL, Oliver BG, and Roth M (2009) Molecular mechanisms of combination therapy with inhaled corticosteroids and long-acting β-agonists. Chest 136:1095-1100.
7. Bos IS, Gosens R, Zuidhof AB, Schaafsma D, Halayko AJ, Meurs H, and Zaagsma J (2007) Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J 30:653-661. (Pubitemid 351194824)
8. 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level. J Biol Chem 264:16786-16792.
9. 2-bronchodilators. Eur J Clin Pharmacol 34:145-150.
10. Brodde OE, Kretsch R, Ikezono K, Zerkowski HR, and Reidemeister JC (1986) Human β-adrenoceptors: relation of myocardial and lymphocyte β-adrenoceptor density. Science 231:1584-1585. (Pubitemid 16050732)
11. Brodde OE, Michel MC, Gordon EP, Sandoval A, Gilbert EM, and Bristow MR (1989) β-Adrenoceptor regulation in the human heart: can it be monitored in circulating lymphocytes? Eur Heart J 10 (Suppl B):2-10. (Pubitemid 19182626)
12. Cheung AH, Dixon RA, Hill WS, Sigal IS, and Strader CD (1990) Separation of the structural requirements for agonist-promoted activation and sequestration of the β-adrenergic receptor. Mol Pharmacol 37:775-779. (Pubitemid 20219883)
13. Clark AR, Martins JR, and Tchen CR (2008) Role of dual specificity phosphatases in biological responses to glucocorticoids. J Biol Chem 283:25765-25769.
14. 2- adrenoceptor tolerance in human small airways but via different mechanisms. Br J Pharmacol 163:521-532.
15. DeWire SM, Ahn S, Lefkowitz RJ, and Shenoy SK (2007) β-Arrestins and cell signaling. Annu Rev Physiol 69:483-510.
16. 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 274:1005-1010.
17. Giembycz MA, Kaur M, Leigh R, and Newton R (2008) A holy grail of asthma management: toward understanding how long-acting β2-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. Br J Pharmacol 153:1090-1104. (Pubitemid 351415494)
18. 2-adrenoceptor signalling in the airways. Eur Respir J 27:1286-1306.
19. Goldsmith AM, Hershenson MB, Wolbert MP, and Bentley JK (2007) Regulation of airway smooth muscle α-actin expression by glucocorticoids. Am J Physiol Lung Cell Mol Physiol 292:L99-L106. (Pubitemid 46103435)
20. Grandoch M, Roscioni SS, and Schmidt M (2010) The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function. Br J Pharmacol 159:265-284.
21. Hadcock JR and Malbon CC (1988) Regulation of β-adrenergic receptors by "permissive"hormones: glucocorticoids increase steady-state levels of receptor mRNA. Proc Natl Acad Sci USA 85:8415-8419. (Pubitemid 19024985)
22. Herman-Gnjidic Z, MacLusky NJ, and Lye SJ (1994) Dexamethasone partially protects the myometrium against β-adrenergic agonist-induced desensitization in vivo in the rat. Am J Obstet Gynecol 171:1651-1659.
23. Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, and Adcock IM (2002) p38 mitogen-activated protein kinase-incued glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol 109:649-657. (Pubitemid 34327193)
24. 2-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol 117:18-24.
25. 2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. Mol Pharmacol 73:203-214.
26. 2-subtype of adrenoceptors mediates inhibition of pro-fibrotic events in human lung fibroblasts. Naunyn Schmiedebergs Arch Pharmacol 384:133-145.
27. Lefkowitz RJ (1998) G protein-coupled receptors. III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization. J Biol Chem 273:18677-18680.
28. Loza MJ and Penn RB (2010) Regulation of T cells in airway disease by beta-agonist. Front Biosci (Schol Ed) 2:969-979.
29. 2-adrenergic receptor transcription in human lung. Am J Physiol 268:L41-L46.
30. 2-adrenergic receptors in vivo. J Clin Invest 96:99-106.
31. 2 adrenergic agonists reversed steroid sensitivity in severe asthma. Mol Pharmacol 80:1128-1135.
32. Michel MC, Pingsmann A, Nohlen M, Siekmann U, and Brodde OE (1989) Decreased myometrial beta-adrenoceptors in women receiving beta-2-adrenergic tocolytic therapy: correlation with lymphocyte beta-adrenoceptors. Clin Pharmacol Ther 45:1-8. (Pubitemid 19047139)
33. Murphy JE, Padilla BE, Hasdemir B, Cottrell GS, and Bunnett NW (2009) Endosomes: a legitimate platform for the signaling train. Proc Natl Acad Sci USA 106:17615-17622.
34. Pelaia G, Cuda G, Vatrella A, Gallelli L, Caraglia M, Marra M, Abbruzzese A, Caputi M, Maselli R, Costanzo FS, et al. (2005) Mitogen-activated protein kinases and asthma. J Cell Physiol 202:642-653. (Pubitemid 40175839)
35. Penn RB (2008) Embracing emerging paradigms of G protein-coupled receptor agonism and signaling to address airway smooth muscle pathobiology in asthma. Naunyn Schmiedebergs Arch Pharmacol 378:149-169.
36. Racke K, Haag S, Babulayan A, and Warnken M (2008) Pulmonary fibroblasts, an emerging target for anti-obstructive drugs. Naunyn Schmiedebergs Arch Pharmacol 378:193-201.
37. 2 agonists on bronchial airwaysmooth muscle cells through synchronised cellular signalling. Lancet 360:1293-1299.
38. 1- and β-adrenergic receptors in mouse cardiomyocytes. Circ Res 86:1047-1053.
39. Todorova L, Gürcan E, Miller-Larsson A, and Westergren-Thorsson G (2006) Lung fibroblast proteoglycan production induced by serum is inhibited by budesonide and formoterol. Am J Respir Cell Mol Biol 34:92-100. (Pubitemid 43042861)
40. Zhang L and Insel PA (2004) The pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells. J Biol Chem 279:20858-20865. (Pubitemid 38656482)